IPP Bureau
Abott gets USFDA approval for leadless pacemaker
By IPP Bureau - April 05, 2022
Aveir VR is specifically designed to be retrieved when therapy needs to evolve or the device needs to be replaced
Trescal launches its single source calibration solution across Australia and New Zealand
By IPP Bureau - April 05, 2022
Trescal provides precision calibration expertise in every industry, geography and instrument across the world
PerkinElmer HTRF and AlphaLISA assay kits for CHO HCP impurities detection and quantification
By IPP Bureau - April 05, 2022
New high-throughput, no-wash assays contribute to the development, manufacture and quality control of safer, more effective biotherapeutics
Alzamend Neuro appoints Dr. Terri Hunter to its Scientific Advisory Board
By IPP Bureau - April 05, 2022
During her tenure at the University of South Florida Dr. Hunter was responsible for managing the patent portfolio associated with Alzamend’s two product candidates, AL001 and AL002
Dr Lal PathLabs to use drones for sample collection and diagnostic access
By IPP Bureau - April 05, 2022
Pilots to be launched across multiple locations in India.
Lupin signs deal with Alvion for cardiometabolic drugs in Southeast Asia
By IPP Bureau - April 05, 2022
Lupin is committed to providing new affordable treatment options to healthcare providers and patients
SRL Diagnostics and Skye Air Mobility join hands to use drones for collection
By IPP Bureau - April 05, 2022
Drones will be used in the Gurugram and Mumbai region to transport pathology samples
Good business performance gives Boehringer Ingelheim tailwind for investment in R&D
By IPP Bureau - April 05, 2022
R&D investment up 11.7% to 4.1 billion EUR in 2021 (20.0% of net sales)
Suven Pharmaceuticals acquires Casper Pharma for Rs 155 crore
By IPP Bureau - April 05, 2022
Casper Pharma is a Hyderabad based SEZ company engaged in the formulations business. Post-purchase of shares, the target entity would become a wholly-owned subsidiary of SPL
BSV strengthens women's health portfolio by acquiring Tidilan brand
By IPP Bureau - April 05, 2022
It is currently available in tablet and injectable dosage forms
IDMA’s two-day Diamond Jubilee celebrations in Mumbai on April 14-15
By IPP Bureau - April 05, 2022
The two-day event will showcase achievements and address issues pertaining to the industry
CanSinoBIO's Covid-19 mRNA vaccine receives clinical trial approval in China
By IPP Bureau - April 04, 2022
CanSinoBIO will continue to focus on developing a variety of innovative preventive vaccines in its diversified product pipeline with proprietary technologies, including the inhaled version of its COVID-19 vaccine, Convidecia
Radiaction Medical receives USFDA clearance for its radiation protection system
By IPP Bureau - April 04, 2022
It also secures US $ 10 million for US launch and commercialization
Novartis announces new organizational structure
By IPP Bureau - April 04, 2022
New simplified structure and operational set-up supports Novartis strategy as a focused medicines company and is designed to power next phase of innovation, growth and productivity
USFDA grants priority review to Roche’s Actemra/RoActemra to treat Covid-19
By IPP Bureau - April 04, 2022
If approved, it will be the first USFDA-approved immunomodulator for the treatment of Covid-19 in hospitalised patients
